For CAR-T, coronavirus brings uneven impact to studies, treatment

Cancer cell therapy, approved only for the very sick, depends on a complex and precisely timed series of steps, all of which could be disrupted by coronavirus' spread. 

For CAR-T, coronavirus brings uneven impact to studies, treatment
Cancer cell therapy, approved only for the very sick, depends on a complex and precisely timed series of steps, all of which could be disrupted by coronavirus' spread.